Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Other Non-Current Assets (2016 - 2025)

Altimmune (ALT) has disclosed Other Non-Current Assets for 16 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets fell 13.06% to $1.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Dec 2025, down 13.06% year-over-year, with the annual reading at $1.4 million for FY2025, 13.06% down from the prior year.
  • Other Non-Current Assets for Q4 2025 was $1.4 million at Altimmune, down from $1.5 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $1.7 million in Q2 2024, with the low at $115300.0 in Q1 2021.
  • Average Other Non-Current Assets over 5 years is $944752.2, with a median of $841500.0 recorded in 2021.
  • The sharpest move saw Other Non-Current Assets surged 968.76% in 2021, then tumbled 45.24% in 2024.
  • Over 5 years, Other Non-Current Assets stood at $872000.0 in 2021, then fell by 29.47% to $615000.0 in 2022, then tumbled by 40.98% to $363000.0 in 2023, then surged by 351.52% to $1.6 million in 2024, then dropped by 13.06% to $1.4 million in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $1.4 million, $1.5 million, and $1.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.